References
- Alam MI, Beg S, Samad A, et al. (2010). Strategy for effective brain drug delivery. Eur J Pharm Sci 40:385–403
- Bao Y, Guo Y, Zhuang X, et al. (2014). d-α-Tocopherol polyethylene glycol succinate-based redox sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm 11:3196–209
- Béduneaua A, Saulnier P, Benoit JP. (2007). Active targeting of brain tumor using nanocarriers. Biomaterials 28:4947–67
- Bissery MC, Guenard D, Gueritte-Voegelein F, et al. (1991). Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845–52
- Burgo LSD, Hernández RM, Orive G, et al. (2014). Nanotherapeutic approaches for brain cancer management. Nanomedicine 10:905–19
- Chandrasekharan P, Maity D, Yong CX, et al. (2011). Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Biomaterials 32:5663–72
- Cui Y, Xu Q, Chow PK, et al. (2013). Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 34:8511–20
- Feng SS. (2006). New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine (Lond) 1:297–309
- Gaillard PJ, Appeldoorn CCM, Dorland R, et al. (2014). Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). PLoS One 9:e82331
- Gan CW, Chien S, Feng SS. (2010). Nanomedicine: enhancement of chemotherapeutic efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr Pharm Des 16:2308–20
- Gan CW, Feng SS. (2010). Transferrin-conjugated nanoparticles of poly (lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood brain barrier. Biomaterials 31:7748–57
- Ha PT, Nguyet, Tran TMN, et al. (2010). The synthesis of poly(lactide)-vitamin ETPGS (PLA-TPGS) copolymer and its utilization to formulate a curcumin nanocarriers. Pham Adv Nat Sci: Nanosci Nanotechnol 1:1–7
- Jones AR, Shusta EV. (2007). Blood–brain barrier transport of therapeutics via receptor mediation. Pharm Res 24:1759–71
- Kim S, Shi Y, Kim JY, et al. (2010). Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction. Expert Opin Drug Deliv 7:49–62
- Kulkarni SA, Feng SS. (2011). Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood–brain barrier. Nanomedicine (Lond) 6:377–94
- Kuo YC, Lin PI, Wang CC. (2011). Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Nanomedicine (Lond) 6:1011–26
- Kutty RV, Chia SL, Setyawati MI, et al. (2015). In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials 63:58–69
- Kutty RV, Feng SS. (2013). Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. Biomaterials 34:10160–71
- Li Y, He H, Jia X, et al. (2012). A dual-targeting nanocarrier based on poly (amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 33:3899–908
- Liu Y, Li K, Pan J, et al. (2010). Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxel. Biomaterials 31:330–8
- Mi Y, Liu Y, Feng SS. (2011). Formulation of docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS (2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 32:4058–66
- Muthu MS, Feng SS. (2009). Pharmaceutical stability aspects of nanomedicines. Nanomedicine (Lond) 4:857–60
- Muthu MS, Feng SS. (2010). Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine (Lond) 5:1017–9
- Muthu MS, Kulkarni SA, Liu Y, Feng SS. (2012). Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond) 7:353–64
- Muthu MS, Kulkarni SA, Xiong J, Feng SS. (2011). Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 421:332–40
- Muthu MS, Kutty RV, Luo Z, et al. (2015b). Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials 39:234–48
- Muthu MS, Leong DT, Mei L, Feng SS. (2014a). Nanotheranostics-application and further development of nanomedicine strategies for advanced theranostics. Theranostics 4:660–77
- Muthu MS, Mei L, Feng SS. (2014b). Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy. Nanomedicine (Lond) 9:1277–80
- Muthu MS, Sahu AK, Sonali S, et al. (2015a). Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Deliv. [Epub ahead of print]. DOI:10.3109/10717544.2014.909907
- Muthu MS, Rajesh CV, Mishra A, Singh S. (2009). Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine (Lond) 4:657–67
- Muthu MS, Singh S. (2009). Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine (Lond) 4:105–18
- Muthu MS, Wilson B. (2010). Multifunctional radionanomedicine: a novel platform for effective cancer imaging and therapy. Nanomedicine (Lond) 5:169–71
- Raju A, Muthu MS, Feng SS. (2013). Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opin Drug Deliv 10:747–60
- Ren WH, Chang J, Yan CH, et al. (2010). Development of transferrin functionalized poly (ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma. J Mater Sci Mater Med 21:2673–81
- Sawant RR, Jhaveri AM, Koshkaryev A, et al. (2014). Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma. Mol Pharm 11:375–81
- Song Q, Tan S, Zhuang X, et al. (2014). Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin. Mol Pharm 11:4118–29
- Ulbrich K, Hekmatara T, Herbert E, Kreuter J. (2009). Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm 71:251–6
- Vijayakumar MR, Muthu MS, Singh S. (2013). Co-polymers of poly (lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Expert Opin Drug Deliv 10:529–43
- Wohlfart S, Gelperina S, Kreuter J. (2012). Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release 161:264–73
- Yue J, Liu S, Wang R, et al. (2012). Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models. Mol Pharm 9:1919–31
- Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33:4889–906
- Zhao J, Mi Y, Feng SS. (2013a). Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials 34:3411–21
- Zhao L, Feng SS. (2010). Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci 99:3552–60
- Zhao S, Tan S, Guo Y, et al. (2013b). pH-Sensitive docetaxel-loaded d-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance. Biomacromolecules 14:2636–46